Chinese bribery crackdown far from over for pharma
This article was originally published in SRA
Executive Summary
While things may appear to have gone quiet regarding the bribery probes in the Chinese pharma sector, the reality is that the government and provincial authorities are continuing to crack down and will do so for years yet.